Phase 1-3 cross-cultural development and pre-testing of the European Organisation of Research and Treatment of Cancer Vulva cancer questionnaire module (EORTC QLQ- VU)
Listen to this summary
The authors aimed to develop and pre-test a quality of life measure specifically for vulva cancer patients to complement the existing EORTC QLQ-C30 questionnaire, ensuring its content validity and cross-cultural adaptability. Through a systematic literature review and input from patients and healthcare professionals, they identified key quality of life issues, resulting in a provisional questionnaire (EORTC QLQ-VU) consisting of 36 items, which underwent pre-testing across multiple European centers. The findings indicated high relevance and applicability of the questionnaire, with further psychometric validation planned.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Gynecologic oncology
View all →Aug 8, 2026 · Gynecologic oncology
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study
Aug 7, 2026 · Gynecologic oncology
Factors associated with non-completion of gynecological cancer clinical trials
Aug 7, 2026 · Gynecologic oncology
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes
Aug 7, 2026 · Gynecologic oncology
Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment
Aug 6, 2026 · Gynecologic oncology
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project
Aug 4, 2026 · Gynecologic oncology
The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma
More in Obstetrics & Gynecology
View all →Aug 9, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
High-Frequency Ultrasound Assessment of Female Genital Rejuvenation
Aug 9, 2026 · Journal of minimally invasive gynecology
Letter to the Editor Regarding "Bowel Injuries Reported After NovaSure Endometrial Ablation: A 10-Year Review of FDA MAUDE Data." Title: "Bowel Injury Following Endometrial Ablation: A Plausible Mechanism and Prevention Strategy."
Aug 9, 2026 · Journal of minimally invasive gynecology
Beyond the Mass Effect: Decoupling Endometrioma Size and Bilaterality from Ovarian Reserve Depletion
Aug 9, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
From ACR O-RADS 2022 to Explainable Deep Learning: Comparative Performance of Expert Radiologists, Convolutional Neural Networks, Vision Transformers, and Fusion Models for Ultrasound-Based Risk Stratification of Ovarian Masses
Aug 9, 2026 · Human reproduction (Oxford, England)
Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study
Aug 8, 2026 · Gynecologic oncology reports
Interval debulking with HIPEC in patient with VP shunt
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


